The University of Birmingham and Bruntwood SciTech have together marked the topping out of No.1 Birmingham Health Innovation Campus (BHIC) – our forthcoming specialist life sciences hub – with a ceremony celebrating the completion of the exterior envelope of the landmark building and the next stage of development.
The ceremony came just days after the team welcomed Liz Truss and Kwasi Kwarteng – accompanied by Mayor of the West Midlands Andy Street – to the new £45m development during the 2022 Conservative Party Conference.
Due to complete in 2024 and led by main contractor John Sisk and Son, No.1 BHIC will provide 133,000 sq ft of specialist lab and office space for innovative life science and digital healthcare companies, in response to increasing demand for space from the sector. It will be home to the Precision Health Technologies Accelerator (PHTA), the University of Birmingham’s flagship life sciences research facility, which will provide opportunities for pioneering R&D start-ups to co-locate and collaborate with scale ups and larger enterprises.
One of only six national Life Sciences Opportunity Zones and identified by the Department for International Trade as a High Potential Opportunity for Data Driven Healthcare, the development forms the first phase of a 10-year masterplan for the 10-acre campus being developed by Bruntwood SciTech, a 50:50 partnership between Bruntwood and Legal & General, in partnership with the University.
Once complete, the campus will provide up to 657,000 sq ft of new commercial lab and office space and is expected to catalyse the growth of the region’s life science sector, creating up to 10,000 local jobs and contributing £400m GVA to the region’s economy. It will sit at the heart of a critical cluster of health excellence in the city; with unparalleled links to the University of Birmingham Hospitals and Birmingham Women’s and Children’s – as well as fellow Birmingham Health Partners organisations Aston University, Sandwell and West Birmingham Hospitals, and the Royal Orthopaedic Hospital.
Businesses locating to BHIC will be closely aligned to the University of Birmingham’s clinical trials facilities, with direct access to a fully connected clinical trials ecosystem. Companies will also benefit from Bruntwood SciTech’s Innovation Services support, which provides direct access to highly skilled specialist talent, funding and finance opportunities, and introductions for opportunities into new markets.
Professor Gino Martini, CEO of PHTA Ltd, commented: “Having PHTA at the heart of the BHIC development means that businesses locating here will be elbow-to-elbow with key opinion leaders and clinical-academics in areas such as clinical trials; complex diagnostics; health data; medical devices and regulatory science. It’s a unique opportunity to commercialise life science innovations and accelerate the development of cutting-edge therapies and technologies, and we can’t wait to move in this time next year.”
Dr Kath Mackay, Director of Life Sciences at Bruntwood SciTech, said: “It has been fantastic to come together in such a celebratory way to reflect on the success of the UK life sciences sector, Birmingham’s contribution to date, and the huge impact BHIC is set to make in the future. The reception this development is receiving from local and national government shows just how much appetite there is for regional centres of excellence that drive prosperity and support local communities.
“With No.1 BHIC now less than a year away from completion, we’re looking forward to opening its doors and welcoming the first businesses to the campus.”
Andy Street, the Mayor of the West Midlands, commented: “No.1 BHIC is an incredibly exciting project for our region – bringing world class R&D to Birmingham and helping to transform health outcomes for local people. I have no doubt that BHIC is set to become a beacon of British ingenuity and scientific excellence. This state of the art facility will result in breakthroughs for patients and healthcare professionals around the world and – crucially – will support economic recovery right across the West Midlands in the months and years ahead.”
Professor Adam Tickell, Vice-Chancellor and Principal of the University of Birmingham, said: “The University is proud of its longstanding collaborative relationship with partner NHS institutions. Our vision and ambition for this site was a dedicated health and life sciences park to enhance Birmingham’s life sciences expertise.
“Through our collaboration with Bruntwood SciTech, our vision is becoming a reality. We are delighted by today’s topping out ceremony, which celebrates the University’s own flagship life sciences research facility, the Precision Health Technologies Accelerator – PHTA Ltd. This building demonstrates our dedication to providing a vibrant space to encourage new ways of thinking, encouraging interdisciplinary work and exploring new opportunities.”
Alan Rodger, Managing Director – UK North, John Sisk & Son said: “Sisk is delighted to reach this important milestone at No.1 BHIC. It gives us time to reflect upon the great work done so far by our client, our staff and supply chain partners. BHIC is one of a number of projects in the Sisk Life Sciences portfolio and contributes to our growing presence across the UK. We are on course to complete No.1 BHIC in Q3 2023 with the campus expected to catalyse the growth of the region’s life science sector. We look forward to works progressing on site and reaching completion over the coming 12 months.”
As the UK’s leading property provider dedicated to the growth of the life science and tech sector, providing world-class specialist workspaces, infrastructure, and support, Bruntwood SciTech will also provide businesses and organisations based at BHIC with access to its UK-wide network of innovation districts of 11 campuses across seven cities – from Cambridge to Glasgow – enabling them to collaborate with a 500-strong specialist community of science and tech businesses.
